500 patients join quest to unravel mysteries of rare scleroderma
NCT ID NCT04265144
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study follows 500 adults with systemic sclerosis (scleroderma) for up to 5 years. Researchers will collect blood samples, and in some volunteers, skin or lung samples, to track how the disease changes over time. The goal is to better understand the natural course of this rare autoimmune disease, which could eventually guide the development of new treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could provide a clearer picture of how systemic sclerosis progresses, helping researchers design better treatments in the future.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly test any new therapy, and results may take years to influence patient care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCLERODERMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Bordeaux - service de rhumatologie
RECRUITINGBordeaux, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a skin patch ease stomach pain in scleroderma?
- Immune clues in the blood may foretell heart trouble
- Blood particles may reveal hidden clues to scleroderma complications
- Could a simple injection dissolve painful calcium lumps in rare diseases?
- Finger injections aim to loosen stiff hands in scleroderma
- Continued anifrolumab treatment studied for lupus and related diseases